Omeros | OMER - Srodki Pieniężne I Ekwiwalent

Cena Akcji
11.49
Dzienna Zmiana
-0.42 -3.53%
Miesięcznie
-3.69%
Rocznie
70.73%
Q2 Prognozy TE
11.18




Srodki Pieniężne I Ekwiwalent Zmiana Data
Adma Biologics USD 87.63M 26.24M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Cytokinetics USD 122.52M 102.95M 2025-12
Gilead Sciences USD 7.33B 2.19B 2025-09
Heron Therapeutics USD 43.07M 26.55M 2025-09
Immunic USD 35.13M 20.18M 2025-09
Insmed USD 510.44M 175.68M 2025-12
Knight Therapeutics CAD 76.45M 5.43M 2025-12
MacroGenics USD 57.22M 22.91M 2025-12
Omeros USD 1.9M 2.36M 2025-06
Pacira USD 158.54M 10.96M 2025-12
Pfizer USD 1.34B 295M 2025-09
Rockwell Medical USD 12.48M 1.09M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
United Therapeutics USD 1.56B 217M 2025-12
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12
Xoma USD 143.9M 7.68M 2024-06